Basilea Bids Farewell To Oncology To Focus On Anti-Infectives

Puts Faith In US Approval Of Antibiotic Zevtera

 
• By Kevin Grogan
  
severing ties and boycott concept
Basilea cutting off its cancer assets • Source: Archive
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business